Skip to content

BioSig Technologies, Inc. STEX Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW
$9.11M+1,486%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$177K+14.2%
TEC
Bio-TechneTECH
$21.67M+38.4%
Boston Scientific logo
Boston ScientificBSX
$2.47B+26.9%
Medtronic logo
MedtronicMDT
$2.06B+16.2%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$198.4M+14.6%

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-56.4%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s other non-current liabilities?
BioSig Technologies, Inc. (STEX) reported other non-current liabilities of $12.85M in Q2 2025.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.